nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—Sepsis—Telbivudine—hepatitis B	0.0059	0.0067	CcSEcCtD
Paroxetine—Myopathy—Lamivudine—hepatitis B	0.00546	0.00621	CcSEcCtD
Paroxetine—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00541	0.00615	CcSEcCtD
Paroxetine—Renal impairment—Telbivudine—hepatitis B	0.00518	0.00589	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00517	0.00587	CcSEcCtD
Paroxetine—Pancreatitis—Entecavir—hepatitis B	0.00509	0.00578	CcSEcCtD
Paroxetine—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00497	0.00564	CcSEcCtD
Paroxetine—Amblyopia—Lamivudine—hepatitis B	0.00496	0.00564	CcSEcCtD
Paroxetine—Hyperaesthesia—Lamivudine—hepatitis B	0.00488	0.00555	CcSEcCtD
Paroxetine—Migraine—Telbivudine—hepatitis B	0.00486	0.00552	CcSEcCtD
Paroxetine—Hyperglycaemia—Entecavir—hepatitis B	0.00468	0.00532	CcSEcCtD
Paroxetine—Dysphonia—Lamivudine—hepatitis B	0.00466	0.00529	CcSEcCtD
Paroxetine—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00458	0.00521	CcSEcCtD
Paroxetine—Acne—Lamivudine—hepatitis B	0.00455	0.00517	CcSEcCtD
Paroxetine—Cramp muscle—Telbivudine—hepatitis B	0.00444	0.00505	CcSEcCtD
Paroxetine—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00444	0.00505	CcSEcCtD
Paroxetine—Haematuria—Entecavir—hepatitis B	0.00441	0.00501	CcSEcCtD
Paroxetine—Nasopharyngitis—Telbivudine—hepatitis B	0.00441	0.00501	CcSEcCtD
Paroxetine—Jaundice—Adefovir Dipivoxil—hepatitis B	0.0044	0.005	CcSEcCtD
Paroxetine—Hepatobiliary disease—Entecavir—hepatitis B	0.00438	0.00497	CcSEcCtD
Paroxetine—Gastritis—Telbivudine—hepatitis B	0.00437	0.00496	CcSEcCtD
Paroxetine—Vasodilation procedure—Lamivudine—hepatitis B	0.00436	0.00495	CcSEcCtD
Paroxetine—Vasodilation—Lamivudine—hepatitis B	0.00436	0.00495	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00435	0.00494	CcSEcCtD
Paroxetine—Muscular weakness—Telbivudine—hepatitis B	0.00435	0.00494	CcSEcCtD
Paroxetine—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00431	0.00489	CcSEcCtD
Paroxetine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00427	0.00485	CcSEcCtD
Paroxetine—Influenza—Telbivudine—hepatitis B	0.00426	0.00485	CcSEcCtD
Paroxetine—Rectal haemorrhage—Lamivudine—hepatitis B	0.00424	0.00482	CcSEcCtD
Paroxetine—Bone disorder—Lamivudine—hepatitis B	0.00424	0.00482	CcSEcCtD
Paroxetine—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00424	0.00481	CcSEcCtD
Paroxetine—Hepatitis—Entecavir—hepatitis B	0.00416	0.00472	CcSEcCtD
Paroxetine—Oedema peripheral—Entecavir—hepatitis B	0.00409	0.00465	CcSEcCtD
Paroxetine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00405	0.00461	CcSEcCtD
Paroxetine—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00405	0.0046	CcSEcCtD
Paroxetine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00402	0.00457	CcSEcCtD
Paroxetine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00398	0.00453	CcSEcCtD
Paroxetine—Muscle twitching—Lamivudine—hepatitis B	0.0039	0.00443	CcSEcCtD
Paroxetine—Eructation—Lamivudine—hepatitis B	0.00376	0.00428	CcSEcCtD
Paroxetine—Immune system disorder—Entecavir—hepatitis B	0.00375	0.00426	CcSEcCtD
Paroxetine—Neuropathy peripheral—Telbivudine—hepatitis B	0.00373	0.00423	CcSEcCtD
Paroxetine—Alopecia—Entecavir—hepatitis B	0.00367	0.00417	CcSEcCtD
Paroxetine—Mental disorder—Entecavir—hepatitis B	0.00364	0.00414	CcSEcCtD
Paroxetine—Malnutrition—Entecavir—hepatitis B	0.00362	0.00411	CcSEcCtD
Paroxetine—Photophobia—Lamivudine—hepatitis B	0.0036	0.00409	CcSEcCtD
Paroxetine—Neuropathy—Lamivudine—hepatitis B	0.0036	0.00409	CcSEcCtD
Paroxetine—Aplastic anaemia—Lamivudine—hepatitis B	0.0036	0.00409	CcSEcCtD
Paroxetine—Hepatobiliary disease—Telbivudine—hepatitis B	0.0036	0.00409	CcSEcCtD
Paroxetine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00353	0.00401	CcSEcCtD
Paroxetine—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00348	0.00395	CcSEcCtD
Paroxetine—Mouth ulceration—Lamivudine—hepatitis B	0.00346	0.00393	CcSEcCtD
Paroxetine—Urine output increased—Lamivudine—hepatitis B	0.00346	0.00393	CcSEcCtD
Paroxetine—Back pain—Adefovir Dipivoxil—hepatitis B	0.00341	0.00388	CcSEcCtD
Paroxetine—Hepatitis—Telbivudine—hepatitis B	0.00341	0.00388	CcSEcCtD
Paroxetine—Hypoaesthesia—Telbivudine—hepatitis B	0.0034	0.00386	CcSEcCtD
Paroxetine—Pharyngitis—Telbivudine—hepatitis B	0.00339	0.00385	CcSEcCtD
Paroxetine—Connective tissue disorder—Telbivudine—hepatitis B	0.00335	0.00381	CcSEcCtD
Paroxetine—Sepsis—Lamivudine—hepatitis B	0.00332	0.00378	CcSEcCtD
Paroxetine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00326	0.00371	CcSEcCtD
Paroxetine—Lymphadenopathy—Lamivudine—hepatitis B	0.00326	0.0037	CcSEcCtD
Paroxetine—Leukopenia—Entecavir—hepatitis B	0.00324	0.00368	CcSEcCtD
Paroxetine—Phlebitis—Lamivudine—hepatitis B	0.00323	0.00367	CcSEcCtD
Paroxetine—Sleep disorder—Lamivudine—hepatitis B	0.00321	0.00365	CcSEcCtD
Paroxetine—Polyuria—Lamivudine—hepatitis B	0.00317	0.0036	CcSEcCtD
Paroxetine—Gastroenteritis—Lamivudine—hepatitis B	0.00314	0.00356	CcSEcCtD
Paroxetine—Deafness—Lamivudine—hepatitis B	0.00311	0.00353	CcSEcCtD
Paroxetine—Cough—Adefovir Dipivoxil—hepatitis B	0.00308	0.0035	CcSEcCtD
Paroxetine—Mediastinal disorder—Telbivudine—hepatitis B	0.00308	0.0035	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00306	0.00347	CcSEcCtD
Paroxetine—Injury—Lamivudine—hepatitis B	0.00303	0.00344	CcSEcCtD
Paroxetine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.003	0.00341	CcSEcCtD
Paroxetine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.003	0.00341	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00298	0.00339	CcSEcCtD
Paroxetine—Malnutrition—Telbivudine—hepatitis B	0.00297	0.00338	CcSEcCtD
Paroxetine—Anaphylactic shock—Entecavir—hepatitis B	0.00295	0.00335	CcSEcCtD
Paroxetine—Infection—Entecavir—hepatitis B	0.00293	0.00333	CcSEcCtD
Paroxetine—Renal impairment—Lamivudine—hepatitis B	0.00292	0.00332	CcSEcCtD
Paroxetine—Thirst—Lamivudine—hepatitis B	0.00292	0.00332	CcSEcCtD
Paroxetine—Dysgeusia—Telbivudine—hepatitis B	0.00291	0.00331	CcSEcCtD
Paroxetine—Nervous system disorder—Entecavir—hepatitis B	0.0029	0.00329	CcSEcCtD
Paroxetine—Back pain—Telbivudine—hepatitis B	0.00287	0.00327	CcSEcCtD
Paroxetine—Skin disorder—Entecavir—hepatitis B	0.00287	0.00326	CcSEcCtD
Paroxetine—Muscle spasms—Telbivudine—hepatitis B	0.00286	0.00325	CcSEcCtD
Paroxetine—Hypoglycaemia—Lamivudine—hepatitis B	0.00285	0.00324	CcSEcCtD
Paroxetine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00282	0.00321	CcSEcCtD
Paroxetine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00282	0.0032	CcSEcCtD
Paroxetine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.0028	0.00318	CcSEcCtD
Paroxetine—Ill-defined disorder—Telbivudine—hepatitis B	0.00276	0.00313	CcSEcCtD
Paroxetine—Affect lability—Lamivudine—hepatitis B	0.00274	0.00311	CcSEcCtD
Paroxetine—Migraine—Lamivudine—hepatitis B	0.00274	0.00311	CcSEcCtD
Paroxetine—Malaise—Telbivudine—hepatitis B	0.00268	0.00304	CcSEcCtD
Paroxetine—Insomnia—Entecavir—hepatitis B	0.00267	0.00303	CcSEcCtD
Paroxetine—Mood swings—Lamivudine—hepatitis B	0.00263	0.00299	CcSEcCtD
Paroxetine—Somnolence—Entecavir—hepatitis B	0.00262	0.00298	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00262	0.00298	CcSEcCtD
Paroxetine—Dyspepsia—Entecavir—hepatitis B	0.0026	0.00295	CcSEcCtD
Paroxetine—Cough—Telbivudine—hepatitis B	0.00259	0.00295	CcSEcCtD
Paroxetine—Dehydration—Lamivudine—hepatitis B	0.00259	0.00294	CcSEcCtD
Paroxetine—Liver function test abnormal—Lamivudine—hepatitis B	0.00257	0.00292	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00255	0.0029	CcSEcCtD
Paroxetine—Fatigue—Entecavir—hepatitis B	0.00255	0.00289	CcSEcCtD
Paroxetine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00254	0.00288	CcSEcCtD
Paroxetine—Arthralgia—Telbivudine—hepatitis B	0.00253	0.00287	CcSEcCtD
Paroxetine—Chest pain—Telbivudine—hepatitis B	0.00253	0.00287	CcSEcCtD
Paroxetine—Myalgia—Telbivudine—hepatitis B	0.00253	0.00287	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00251	0.00285	CcSEcCtD
Paroxetine—Cramp muscle—Lamivudine—hepatitis B	0.0025	0.00284	CcSEcCtD
Paroxetine—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.0025	0.00284	CcSEcCtD
Paroxetine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.0025	0.00284	CcSEcCtD
Paroxetine—Discomfort—Telbivudine—hepatitis B	0.0025	0.00284	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00249	0.00283	CcSEcCtD
Paroxetine—Nasopharyngitis—Lamivudine—hepatitis B	0.00249	0.00283	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00245	0.00279	CcSEcCtD
Paroxetine—Muscular weakness—Lamivudine—hepatitis B	0.00245	0.00279	CcSEcCtD
Paroxetine—Gastrointestinal pain—Entecavir—hepatitis B	0.00241	0.00274	CcSEcCtD
Paroxetine—Dysphagia—Lamivudine—hepatitis B	0.0024	0.00273	CcSEcCtD
Paroxetine—Influenza—Lamivudine—hepatitis B	0.0024	0.00273	CcSEcCtD
Paroxetine—Nervous system disorder—Telbivudine—hepatitis B	0.00238	0.0027	CcSEcCtD
Paroxetine—Thrombocytopenia—Telbivudine—hepatitis B	0.00237	0.0027	CcSEcCtD
Paroxetine—Pancreatitis—Lamivudine—hepatitis B	0.00236	0.00268	CcSEcCtD
Paroxetine—Skin disorder—Telbivudine—hepatitis B	0.00236	0.00268	CcSEcCtD
Paroxetine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00236	0.00268	CcSEcCtD
Paroxetine—Sweating increased—Lamivudine—hepatitis B	0.00234	0.00266	CcSEcCtD
Paroxetine—Body temperature increased—Entecavir—hepatitis B	0.00233	0.00265	CcSEcCtD
Paroxetine—Abdominal pain—Entecavir—hepatitis B	0.00233	0.00265	CcSEcCtD
Paroxetine—Bronchitis—Lamivudine—hepatitis B	0.00231	0.00263	CcSEcCtD
Paroxetine—Pancytopenia—Lamivudine—hepatitis B	0.00228	0.00259	CcSEcCtD
Paroxetine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00228	0.00259	CcSEcCtD
Paroxetine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00228	0.00259	CcSEcCtD
Paroxetine—Dysuria—Lamivudine—hepatitis B	0.00225	0.00255	CcSEcCtD
Paroxetine—Pollakiuria—Lamivudine—hepatitis B	0.00222	0.00252	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00221	0.00251	CcSEcCtD
Paroxetine—Insomnia—Telbivudine—hepatitis B	0.00219	0.00249	CcSEcCtD
Paroxetine—Paraesthesia—Telbivudine—hepatitis B	0.00218	0.00247	CcSEcCtD
Paroxetine—Hyperglycaemia—Lamivudine—hepatitis B	0.00217	0.00246	CcSEcCtD
Paroxetine—Depression—Lamivudine—hepatitis B	0.00214	0.00243	CcSEcCtD
Paroxetine—Dyspepsia—Telbivudine—hepatitis B	0.00213	0.00243	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00212	0.00241	CcSEcCtD
Paroxetine—Asthenia—Entecavir—hepatitis B	0.00212	0.00241	CcSEcCtD
Paroxetine—Neuropathy peripheral—Lamivudine—hepatitis B	0.0021	0.00239	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00209	0.00238	CcSEcCtD
Paroxetine—Fatigue—Telbivudine—hepatitis B	0.00209	0.00238	CcSEcCtD
Paroxetine—Jaundice—Lamivudine—hepatitis B	0.00209	0.00237	CcSEcCtD
Paroxetine—Stomatitis—Lamivudine—hepatitis B	0.00209	0.00237	CcSEcCtD
Paroxetine—Pain—Telbivudine—hepatitis B	0.00207	0.00236	CcSEcCtD
Paroxetine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00207	0.00235	CcSEcCtD
Paroxetine—Sweating—Lamivudine—hepatitis B	0.00205	0.00233	CcSEcCtD
Paroxetine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00204	0.00232	CcSEcCtD
Paroxetine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00203	0.0023	CcSEcCtD
Paroxetine—Epistaxis—Lamivudine—hepatitis B	0.00202	0.0023	CcSEcCtD
Paroxetine—Diarrhoea—Entecavir—hepatitis B	0.00202	0.00229	CcSEcCtD
Paroxetine—Sinusitis—Lamivudine—hepatitis B	0.00201	0.00228	CcSEcCtD
Paroxetine—Agranulocytosis—Lamivudine—hepatitis B	0.002	0.00227	CcSEcCtD
Paroxetine—Feeling abnormal—Telbivudine—hepatitis B	0.002	0.00227	CcSEcCtD
Paroxetine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00198	0.00225	CcSEcCtD
Paroxetine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00197	0.00224	CcSEcCtD
Paroxetine—Dizziness—Entecavir—hepatitis B	0.00195	0.00222	CcSEcCtD
Paroxetine—Rhinitis—Lamivudine—hepatitis B	0.00193	0.00219	CcSEcCtD
Paroxetine—Hepatitis—Lamivudine—hepatitis B	0.00192	0.00219	CcSEcCtD
Paroxetine—Abdominal pain—Telbivudine—hepatitis B	0.00192	0.00218	CcSEcCtD
Paroxetine—Body temperature increased—Telbivudine—hepatitis B	0.00192	0.00218	CcSEcCtD
Paroxetine—Hypoaesthesia—Lamivudine—hepatitis B	0.00191	0.00217	CcSEcCtD
Paroxetine—Pharyngitis—Lamivudine—hepatitis B	0.00191	0.00217	CcSEcCtD
Paroxetine—Connective tissue disorder—Lamivudine—hepatitis B	0.00189	0.00215	CcSEcCtD
Paroxetine—Vomiting—Entecavir—hepatitis B	0.00188	0.00213	CcSEcCtD
Paroxetine—Rash—Entecavir—hepatitis B	0.00186	0.00211	CcSEcCtD
Paroxetine—Dermatitis—Entecavir—hepatitis B	0.00186	0.00211	CcSEcCtD
Paroxetine—Headache—Entecavir—hepatitis B	0.00185	0.0021	CcSEcCtD
Paroxetine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00183	0.00208	CcSEcCtD
Paroxetine—Erythema multiforme—Lamivudine—hepatitis B	0.00182	0.00207	CcSEcCtD
Paroxetine—Rash—Adefovir Dipivoxil—hepatitis B	0.00182	0.00206	CcSEcCtD
Paroxetine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00181	0.00206	CcSEcCtD
Paroxetine—Headache—Adefovir Dipivoxil—hepatitis B	0.0018	0.00205	CcSEcCtD
Paroxetine—Nausea—Entecavir—hepatitis B	0.00175	0.00199	CcSEcCtD
Paroxetine—Asthenia—Telbivudine—hepatitis B	0.00174	0.00198	CcSEcCtD
Paroxetine—Immune system disorder—Lamivudine—hepatitis B	0.00174	0.00197	CcSEcCtD
Paroxetine—Mediastinal disorder—Lamivudine—hepatitis B	0.00173	0.00197	CcSEcCtD
Paroxetine—Chills—Lamivudine—hepatitis B	0.00173	0.00196	CcSEcCtD
Paroxetine—Pruritus—Telbivudine—hepatitis B	0.00172	0.00195	CcSEcCtD
Paroxetine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00171	0.00194	CcSEcCtD
Paroxetine—Alopecia—Lamivudine—hepatitis B	0.0017	0.00193	CcSEcCtD
Paroxetine—Erythema—Lamivudine—hepatitis B	0.00167	0.0019	CcSEcCtD
Paroxetine—Malnutrition—Lamivudine—hepatitis B	0.00167	0.0019	CcSEcCtD
Paroxetine—Diarrhoea—Telbivudine—hepatitis B	0.00166	0.00189	CcSEcCtD
Paroxetine—Flatulence—Lamivudine—hepatitis B	0.00165	0.00187	CcSEcCtD
Paroxetine—Tension—Lamivudine—hepatitis B	0.00164	0.00187	CcSEcCtD
Paroxetine—Dysgeusia—Lamivudine—hepatitis B	0.00164	0.00186	CcSEcCtD
Paroxetine—Nervousness—Lamivudine—hepatitis B	0.00163	0.00185	CcSEcCtD
Paroxetine—Back pain—Lamivudine—hepatitis B	0.00162	0.00184	CcSEcCtD
Paroxetine—Muscle spasms—Lamivudine—hepatitis B	0.00161	0.00183	CcSEcCtD
Paroxetine—Dizziness—Telbivudine—hepatitis B	0.0016	0.00182	CcSEcCtD
Paroxetine—Tremor—Lamivudine—hepatitis B	0.00157	0.00178	CcSEcCtD
Paroxetine—Ill-defined disorder—Lamivudine—hepatitis B	0.00155	0.00177	CcSEcCtD
Paroxetine—Anaemia—Lamivudine—hepatitis B	0.00155	0.00176	CcSEcCtD
Paroxetine—Vomiting—Telbivudine—hepatitis B	0.00154	0.00175	CcSEcCtD
Paroxetine—Angioedema—Lamivudine—hepatitis B	0.00153	0.00174	CcSEcCtD
Paroxetine—Rash—Telbivudine—hepatitis B	0.00153	0.00174	CcSEcCtD
Paroxetine—Dermatitis—Telbivudine—hepatitis B	0.00153	0.00174	CcSEcCtD
Paroxetine—Headache—Telbivudine—hepatitis B	0.00152	0.00173	CcSEcCtD
Paroxetine—Malaise—Lamivudine—hepatitis B	0.00151	0.00172	CcSEcCtD
Paroxetine—Vertigo—Lamivudine—hepatitis B	0.0015	0.00171	CcSEcCtD
Paroxetine—Syncope—Lamivudine—hepatitis B	0.0015	0.00171	CcSEcCtD
Paroxetine—Leukopenia—Lamivudine—hepatitis B	0.0015	0.0017	CcSEcCtD
Paroxetine—Loss of consciousness—Lamivudine—hepatitis B	0.00147	0.00167	CcSEcCtD
Paroxetine—Cough—Lamivudine—hepatitis B	0.00146	0.00166	CcSEcCtD
Paroxetine—Convulsion—Lamivudine—hepatitis B	0.00145	0.00165	CcSEcCtD
Paroxetine—Nausea—Telbivudine—hepatitis B	0.00144	0.00164	CcSEcCtD
Paroxetine—Chest pain—Lamivudine—hepatitis B	0.00143	0.00162	CcSEcCtD
Paroxetine—Myalgia—Lamivudine—hepatitis B	0.00143	0.00162	CcSEcCtD
Paroxetine—Arthralgia—Lamivudine—hepatitis B	0.00143	0.00162	CcSEcCtD
Paroxetine—Anxiety—Lamivudine—hepatitis B	0.00142	0.00161	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00142	0.00161	CcSEcCtD
Paroxetine—Discomfort—Lamivudine—hepatitis B	0.00141	0.0016	CcSEcCtD
Paroxetine—Dry mouth—Lamivudine—hepatitis B	0.00139	0.00158	CcSEcCtD
Paroxetine—Confusional state—Lamivudine—hepatitis B	0.00138	0.00157	CcSEcCtD
Paroxetine—Anaphylactic shock—Lamivudine—hepatitis B	0.00137	0.00155	CcSEcCtD
Paroxetine—Oedema—Lamivudine—hepatitis B	0.00137	0.00155	CcSEcCtD
Paroxetine—Infection—Lamivudine—hepatitis B	0.00136	0.00154	CcSEcCtD
Paroxetine—Shock—Lamivudine—hepatitis B	0.00134	0.00153	CcSEcCtD
Paroxetine—Nervous system disorder—Lamivudine—hepatitis B	0.00134	0.00152	CcSEcCtD
Paroxetine—Thrombocytopenia—Lamivudine—hepatitis B	0.00134	0.00152	CcSEcCtD
Paroxetine—Skin disorder—Lamivudine—hepatitis B	0.00133	0.00151	CcSEcCtD
Paroxetine—Hyperhidrosis—Lamivudine—hepatitis B	0.00132	0.0015	CcSEcCtD
Paroxetine—Hypotension—Lamivudine—hepatitis B	0.00128	0.00145	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00125	0.00141	CcSEcCtD
Paroxetine—Insomnia—Lamivudine—hepatitis B	0.00124	0.0014	CcSEcCtD
Paroxetine—Paraesthesia—Lamivudine—hepatitis B	0.00123	0.00139	CcSEcCtD
Paroxetine—Dyspnoea—Lamivudine—hepatitis B	0.00122	0.00138	CcSEcCtD
Paroxetine—Somnolence—Lamivudine—hepatitis B	0.00122	0.00138	CcSEcCtD
Paroxetine—Dyspepsia—Lamivudine—hepatitis B	0.0012	0.00137	CcSEcCtD
Paroxetine—Decreased appetite—Lamivudine—hepatitis B	0.00119	0.00135	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00118	0.00134	CcSEcCtD
Paroxetine—Fatigue—Lamivudine—hepatitis B	0.00118	0.00134	CcSEcCtD
Paroxetine—Pain—Lamivudine—hepatitis B	0.00117	0.00133	CcSEcCtD
Paroxetine—Constipation—Lamivudine—hepatitis B	0.00117	0.00133	CcSEcCtD
Paroxetine—Feeling abnormal—Lamivudine—hepatitis B	0.00113	0.00128	CcSEcCtD
Paroxetine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00112	0.00127	CcSEcCtD
Paroxetine—Urticaria—Lamivudine—hepatitis B	0.00109	0.00123	CcSEcCtD
Paroxetine—Abdominal pain—Lamivudine—hepatitis B	0.00108	0.00123	CcSEcCtD
Paroxetine—Body temperature increased—Lamivudine—hepatitis B	0.00108	0.00123	CcSEcCtD
Paroxetine—Hypersensitivity—Lamivudine—hepatitis B	0.00101	0.00114	CcSEcCtD
Paroxetine—Asthenia—Lamivudine—hepatitis B	0.000981	0.00111	CcSEcCtD
Paroxetine—Pruritus—Lamivudine—hepatitis B	0.000967	0.0011	CcSEcCtD
Paroxetine—Diarrhoea—Lamivudine—hepatitis B	0.000935	0.00106	CcSEcCtD
Paroxetine—Dizziness—Lamivudine—hepatitis B	0.000904	0.00103	CcSEcCtD
Paroxetine—Vomiting—Lamivudine—hepatitis B	0.000869	0.000987	CcSEcCtD
Paroxetine—Rash—Lamivudine—hepatitis B	0.000862	0.000979	CcSEcCtD
Paroxetine—Dermatitis—Lamivudine—hepatitis B	0.000861	0.000978	CcSEcCtD
Paroxetine—Headache—Lamivudine—hepatitis B	0.000856	0.000973	CcSEcCtD
Paroxetine—Nausea—Lamivudine—hepatitis B	0.000812	0.000922	CcSEcCtD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000149	0.00124	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000148	0.00124	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000148	0.00123	CbGpPWpGaD
Paroxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000147	0.00122	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—CXCL10—hepatitis B	0.000146	0.00122	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000146	0.00122	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—CXCL10—hepatitis B	0.000145	0.00121	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000145	0.00121	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—CXCL10—hepatitis B	0.000145	0.00121	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—CXCL10—hepatitis B	0.000144	0.0012	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—F2—hepatitis B	0.000143	0.0012	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000143	0.00119	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CXCL10—hepatitis B	0.000142	0.00119	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000142	0.00119	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000141	0.00117	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000138	0.00115	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000138	0.00115	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—F2—hepatitis B	0.000137	0.00115	CbGpPWpGaD
Paroxetine—SLC6A4—Circadian rythm related genes—TP53—hepatitis B	0.000131	0.00109	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000128	0.00107	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000127	0.00106	CbGpPWpGaD
Paroxetine—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000127	0.00106	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000127	0.00106	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000125	0.00105	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—CXCL10—hepatitis B	0.000122	0.00102	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—AKR1B1—hepatitis B	0.00012	0.001	CbGpPWpGaD
Paroxetine—SLC6A4—Circadian rythm related genes—IL6—hepatitis B	0.00012	0.000999	CbGpPWpGaD
Paroxetine—TACR1—GPCR downstream signaling—IL2—hepatitis B	0.000119	0.000993	CbGpPWpGaD
Paroxetine—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000119	0.00099	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—CXCL10—hepatitis B	0.000117	0.000974	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GGT2—hepatitis B	0.000115	0.000963	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—PTEN—hepatitis B	0.000115	0.000958	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—CCR5—hepatitis B	0.000113	0.000946	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—CCR5—hepatitis B	0.000113	0.000941	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—CCR5—hepatitis B	0.000112	0.000938	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RIT2—hepatitis B	0.000112	0.000937	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SAG—hepatitis B	0.000112	0.000937	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SAG—hepatitis B	0.000112	0.000932	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RIT2—hepatitis B	0.000112	0.000932	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—CCR5—hepatitis B	0.000111	0.000929	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SAG—hepatitis B	0.000111	0.000929	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RIT2—hepatitis B	0.000111	0.000929	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—CXCL10—hepatitis B	0.000111	0.000924	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CCR5—hepatitis B	0.00011	0.000922	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SAG—hepatitis B	0.00011	0.00092	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RIT2—hepatitis B	0.00011	0.00092	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000109	0.000913	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—IL2—hepatitis B	0.000108	0.000901	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000107	0.000896	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—CXCL10—hepatitis B	0.000106	0.000885	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—AKR1B1—hepatitis B	0.000104	0.000865	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GGT2—hepatitis B	9.93e-05	0.000829	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—F2—hepatitis B	9.73e-05	0.000812	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—F2—hepatitis B	9.67e-05	0.000808	CbGpPWpGaD
Paroxetine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	9.65e-05	0.000805	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—F2—hepatitis B	9.64e-05	0.000805	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—F2—hepatitis B	9.55e-05	0.000797	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—F2—hepatitis B	9.47e-05	0.000791	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—CCR5—hepatitis B	9.45e-05	0.000789	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—CCR5—hepatitis B	9.05e-05	0.000755	CbGpPWpGaD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—ALB—hepatitis B	8.93e-05	0.000746	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.93e-05	0.000745	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—IL6—hepatitis B	8.83e-05	0.000737	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—AKR1B1—hepatitis B	8.77e-05	0.000732	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—IL6—hepatitis B	8.67e-05	0.000723	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—CCR5—hepatitis B	8.58e-05	0.000716	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GGT2—hepatitis B	8.41e-05	0.000702	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CXCL10—hepatitis B	8.26e-05	0.00069	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—CCR5—hepatitis B	8.22e-05	0.000686	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CXCL10—hepatitis B	8.22e-05	0.000686	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CXCL10—hepatitis B	8.19e-05	0.000684	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CXCL10—hepatitis B	8.11e-05	0.000677	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—F2—hepatitis B	8.11e-05	0.000677	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—ALB—hepatitis B	7.91e-05	0.000661	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—TP53—hepatitis B	7.83e-05	0.000654	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—F2—hepatitis B	7.76e-05	0.000648	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	7.76e-05	0.000647	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—AKR1B1—hepatitis B	7.64e-05	0.000638	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	7.58e-05	0.000632	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	7.56e-05	0.000631	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	7.52e-05	0.000628	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CXCL10—hepatitis B	7.5e-05	0.000626	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CXCL10—hepatitis B	7.46e-05	0.000623	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CXCL10—hepatitis B	7.44e-05	0.000621	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CXCL10—hepatitis B	7.37e-05	0.000615	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—F2—hepatitis B	7.36e-05	0.000615	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GGT2—hepatitis B	7.32e-05	0.000611	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	7.27e-05	0.000607	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—AKR1B1—hepatitis B	7.2e-05	0.000601	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—IL6—hepatitis B	7.17e-05	0.000598	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—AKR1B1—hepatitis B	7.14e-05	0.000596	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—F2—hepatitis B	7.05e-05	0.000589	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CYP2A6—hepatitis B	6.99e-05	0.000584	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GGT2—hepatitis B	6.9e-05	0.000576	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GGT2—hepatitis B	6.84e-05	0.000571	CbGpPWpGaD
Paroxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	6.83e-05	0.00057	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	6.79e-05	0.000567	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	6.77e-05	0.000565	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCL10—hepatitis B	6.54e-05	0.000546	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CCR5—hepatitis B	6.41e-05	0.000535	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL2—hepatitis B	6.38e-05	0.000533	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CCR5—hepatitis B	6.37e-05	0.000532	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CCR5—hepatitis B	6.35e-05	0.00053	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—IL6—hepatitis B	6.35e-05	0.00053	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GOT2—hepatitis B	6.32e-05	0.000528	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CCR5—hepatitis B	6.29e-05	0.000525	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	6.27e-05	0.000523	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL10—hepatitis B	6.26e-05	0.000523	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CTNNB1—hepatitis B	6.16e-05	0.000514	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CDKN1A—hepatitis B	6.02e-05	0.000502	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CYP2A6—hepatitis B	6.02e-05	0.000502	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—PTEN—hepatitis B	6e-05	0.000501	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—NFKB1—hepatitis B	5.97e-05	0.000499	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	5.85e-05	0.000488	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CCR5—hepatitis B	5.82e-05	0.000486	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CCR5—hepatitis B	5.79e-05	0.000483	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CCR5—hepatitis B	5.77e-05	0.000482	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CCR5—hepatitis B	5.71e-05	0.000477	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—F2—hepatitis B	5.5e-05	0.000459	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—F2—hepatitis B	5.47e-05	0.000456	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—IL2—hepatitis B	5.46e-05	0.000456	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GOT1—hepatitis B	5.46e-05	0.000456	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GGT1—hepatitis B	5.46e-05	0.000456	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—F2—hepatitis B	5.45e-05	0.000455	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GOT2—hepatitis B	5.44e-05	0.000454	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—F2—hepatitis B	5.4e-05	0.000451	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—IL2—hepatitis B	5.23e-05	0.000437	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	5.16e-05	0.000431	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CYP2A6—hepatitis B	5.09e-05	0.000425	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCR5—hepatitis B	5.07e-05	0.000423	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—F2—hepatitis B	4.99e-05	0.000417	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TGFB1—hepatitis B	4.98e-05	0.000415	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—F2—hepatitis B	4.96e-05	0.000414	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL2—hepatitis B	4.96e-05	0.000414	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—F2—hepatitis B	4.95e-05	0.000413	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—F2—hepatitis B	4.9e-05	0.000409	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCR5—hepatitis B	4.86e-05	0.000405	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.75e-05	0.000396	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL2—hepatitis B	4.75e-05	0.000396	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GOT1—hepatitis B	4.7e-05	0.000392	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GGT1—hepatitis B	4.7e-05	0.000392	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GOT2—hepatitis B	4.61e-05	0.000384	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CYP2A6—hepatitis B	4.44e-05	0.00037	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL10—hepatitis B	4.43e-05	0.00037	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL10—hepatitis B	4.41e-05	0.000368	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL10—hepatitis B	4.39e-05	0.000367	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL10—hepatitis B	4.35e-05	0.000363	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—F2—hepatitis B	4.35e-05	0.000363	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CYP2A6—hepatitis B	4.18e-05	0.000349	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—F2—hepatitis B	4.17e-05	0.000348	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CYP2A6—hepatitis B	4.15e-05	0.000346	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TP53—hepatitis B	4.1e-05	0.000342	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GOT2—hepatitis B	4.01e-05	0.000335	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GGT1—hepatitis B	3.98e-05	0.000332	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GOT1—hepatitis B	3.98e-05	0.000332	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	3.93e-05	0.000328	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.86e-05	0.000323	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GOT2—hepatitis B	3.78e-05	0.000316	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL6—hepatitis B	3.75e-05	0.000313	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GOT2—hepatitis B	3.75e-05	0.000313	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2—hepatitis B	3.7e-05	0.000309	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2—hepatitis B	3.68e-05	0.000307	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2—hepatitis B	3.67e-05	0.000306	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2—hepatitis B	3.63e-05	0.000303	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.62e-05	0.000302	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GOT1—hepatitis B	3.46e-05	0.000289	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GGT1—hepatitis B	3.46e-05	0.000289	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR5—hepatitis B	3.44e-05	0.000287	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR5—hepatitis B	3.42e-05	0.000285	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR5—hepatitis B	3.41e-05	0.000284	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR5—hepatitis B	3.37e-05	0.000282	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2—hepatitis B	3.36e-05	0.000281	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2—hepatitis B	3.34e-05	0.000279	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2—hepatitis B	3.33e-05	0.000278	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2—hepatitis B	3.3e-05	0.000276	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GGT1—hepatitis B	3.26e-05	0.000272	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GOT1—hepatitis B	3.26e-05	0.000272	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GOT1—hepatitis B	3.24e-05	0.00027	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GGT1—hepatitis B	3.24e-05	0.00027	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.95e-05	0.000246	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—F2—hepatitis B	2.95e-05	0.000246	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—F2—hepatitis B	2.93e-05	0.000245	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2—hepatitis B	2.93e-05	0.000245	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—F2—hepatitis B	2.92e-05	0.000244	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL6—hepatitis B	2.91e-05	0.000243	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALB—hepatitis B	2.9e-05	0.000242	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—F2—hepatitis B	2.9e-05	0.000242	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CTNNB1—hepatitis B	2.83e-05	0.000236	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2—hepatitis B	2.81e-05	0.000234	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—hepatitis B	2.79e-05	0.000233	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CDKN1A—hepatitis B	2.76e-05	0.000231	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PTEN—hepatitis B	2.76e-05	0.00023	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NFKB1—hepatitis B	2.74e-05	0.000229	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CTNNB1—hepatitis B	2.71e-05	0.000226	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CDKN1A—hepatitis B	2.65e-05	0.000221	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PTEN—hepatitis B	2.64e-05	0.00022	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NFKB1—hepatitis B	2.63e-05	0.000219	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—hepatitis B	2.5e-05	0.000209	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TGFB1—hepatitis B	2.28e-05	0.000191	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTEN—hepatitis B	2.22e-05	0.000185	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TGFB1—hepatitis B	2.19e-05	0.000183	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—hepatitis B	2.11e-05	0.000177	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2—hepatitis B	1.99e-05	0.000166	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—hepatitis B	1.98e-05	0.000165	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2—hepatitis B	1.98e-05	0.000165	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2—hepatitis B	1.97e-05	0.000164	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—hepatitis B	1.97e-05	0.000164	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—hepatitis B	1.96e-05	0.000164	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2—hepatitis B	1.95e-05	0.000163	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—hepatitis B	1.94e-05	0.000162	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CTNNB1—hepatitis B	1.92e-05	0.00016	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CTNNB1—hepatitis B	1.91e-05	0.000159	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTEN—hepatitis B	1.91e-05	0.000159	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CTNNB1—hepatitis B	1.9e-05	0.000159	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CTNNB1—hepatitis B	1.88e-05	0.000157	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TP53—hepatitis B	1.88e-05	0.000157	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CDKN1A—hepatitis B	1.87e-05	0.000156	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PTEN—hepatitis B	1.87e-05	0.000156	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CDKN1A—hepatitis B	1.86e-05	0.000155	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NFKB1—hepatitis B	1.86e-05	0.000155	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PTEN—hepatitis B	1.86e-05	0.000155	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CDKN1A—hepatitis B	1.86e-05	0.000155	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PTEN—hepatitis B	1.85e-05	0.000155	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NFKB1—hepatitis B	1.85e-05	0.000154	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NFKB1—hepatitis B	1.84e-05	0.000154	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—hepatitis B	1.84e-05	0.000154	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CDKN1A—hepatitis B	1.84e-05	0.000153	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PTEN—hepatitis B	1.83e-05	0.000153	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NFKB1—hepatitis B	1.83e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TP53—hepatitis B	1.8e-05	0.00015	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—hepatitis B	1.74e-05	0.000145	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—hepatitis B	1.72e-05	0.000144	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—hepatitis B	1.72e-05	0.000144	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—hepatitis B	1.65e-05	0.000138	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTEN—hepatitis B	1.61e-05	0.000135	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TGFB1—hepatitis B	1.55e-05	0.000129	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TGFB1—hepatitis B	1.54e-05	0.000129	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TGFB1—hepatitis B	1.54e-05	0.000128	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TGFB1—hepatitis B	1.52e-05	0.000127	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTEN—hepatitis B	1.41e-05	0.000117	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTEN—hepatitis B	1.32e-05	0.000111	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTEN—hepatitis B	1.31e-05	0.00011	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TP53—hepatitis B	1.28e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TP53—hepatitis B	1.27e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TP53—hepatitis B	1.26e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TP53—hepatitis B	1.25e-05	0.000105	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—hepatitis B	1.17e-05	9.74e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—hepatitis B	1.16e-05	9.69e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—hepatitis B	1.16e-05	9.66e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—hepatitis B	1.15e-05	9.57e-05	CbGpPWpGaD
